
FDA Says J&J 1-Dose Shot Prevents COVID, Final Decision Soon
WASHINGTON (AP) -- An analysis by U.S. regulators says Johnson & Johnson's single-dose vaccine protects against COVID-19.
The report Wednesday confirmed that overall the vaccine is about 66% effective at preventing moderate to severe COVID-19.
On Friday, a panel of experts to the Food and Drug Administration will debate if the evidence is strong enough to recommend the long-anticipated shot. The FDA is expected to make a final decision within days.
If the FDA clears the J&J shot for U.S. use, it won't boost vaccine supplies significantly right away. Only a few million doses are expected to be ready for shipping in the first week.

Get our free mobile app
Emerging Players with the Minnesota Timberwolves
More From 104-5 KDAT

![Courtlin’s Ten Favorite Songs of 2023 [LISTEN]](http://townsquare.media/site/675/files/2023/12/attachment-Untitled-design-85.jpg?w=980&q=75)




![Interior of Eastern Iowa Shopping Mall Breaks Our Heart [WATCH]](http://townsquare.media/site/675/files/2023/11/attachment-VS-GOINGBACKTOTHEMALLCHRISTMAS2023ItssadtoseehowthemallisthistimeofyeartodayIremembergoingherewithmyfamilyInstagram-0%2525E2%252580%25259947%2525E2%252580%25259D.jpg?w=980&q=75)

